What is Ciwit B.V.?
Ciwit B.V. provides a sophisticated clinical data management platform designed to streamline the lifecycle of medical research. Its core product, Castor EDC, offers a cloud-native environment where researchers can design complex case report forms, capture patient data in real-time, and manage trial information with high precision. By focusing on user-friendly technology that supports regulatory compliance, the company addresses the critical need for efficiency in the pharmaceutical and healthcare sectors.
The platform serves a diverse clientele, including contract research organizations and healthcare providers, effectively bridging the gap between traditional trial management and modern digital health solutions. As the industry shifts toward decentralized and hybrid clinical trials, Ciwit B.V. remains a pivotal technology partner, providing the necessary tools to ensure data integrity and accelerate the time-to-market for breakthrough medical therapies.
How much funding has Ciwit B.V. raised?
Ciwit B.V. has raised a total of $58.2M across 3 funding rounds:
Grant
$1.2M
Series A
$12M
Series B
$45M
Grant (2017): $1.2M, investors not publicly disclosed
Series A (2020): $12M led by Two Sigma Ventures, INKEF Capital, and Hambrecht Ducera Growth Ventures
Series B (2021): $45M supported by Two Sigma Ventures, INKEF Capital, Eight Roads, and F-Prime Capital Partners
Key Investors in Ciwit B.V.
Two Sigma Ventures
An early-stage venture capital firm that invests in transformative companies leveraging information growth and computing power, with a specific focus on breakthrough therapies and data-driven transformation.
INKEF Capital
An Amsterdam-based venture capital firm that focuses on long-term collaboration and active support of innovative technology companies within the healthcare, IT, and FinTech sectors.
Eight Roads
A global venture capital investment company specializing in supporting growth-stage businesses and providing the necessary capital to scale operations in competitive markets.
What's next for Ciwit B.V.?
With the support of its latest strategic financing, Ciwit B.V. is poised to scale its operations and expand its footprint in the international clinical research market. The company is expected to prioritize the integration of advanced analytics and artificial intelligence into its EDC platform, further automating data collection and reducing the administrative burden on research teams.
Looking ahead, the firm will likely focus on deepening its penetration within the pharmaceutical sector, where the demand for robust, compliant, and scalable data management systems is at an all-time high. By maintaining its commitment to innovation and user-centric design, Ciwit B.V. is set to play a central role in the future of clinical trial management, potentially setting new benchmarks for how medical data is collected, analyzed, and utilized in the pursuit of global health advancements.
